AP-102 is a bioactive compound. References: Beydoun T, Deloche C, Perino J, Kirwan BA, Combette JM, Behar-Cohen F. Subconjunctival injection of XG-102, a JNK inhibitor peptide, in patients with intraocular inflammation: a safety and tolerability study. J Ocul Pharmacol Ther. 2015 Mar;31(2):93-9. doi: 10.1089/jop.2013.0247. Epub 2014 Oct 27. PubMed PMID: 25347151.

纯度：≥98%

CAS：846569-60-6